SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 4,734.42 |
Enterprise Value ($M) | 12,801.42 |
Book Value ($M) | -589.00 |
Book Value / Share | -2.30 |
Price / Book | -8.04 |
NCAV ($M) | -7,620.00 |
NCAV / Share | -29.81 |
Price / NCAV | -0.62 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.12 |
Return on Assets (ROA) | 0.10 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.09 |
Current Ratio | 1.54 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 4,508.00 |
Assets | 12,058.00 |
Liabilities | 12,128.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 6,263.00 |
Operating Income | 1,564.00 |
Net Income | 1,023.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 799.00 |
Cash from Investing | -260.00 |
Cash from Financing | -569.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 11.97 | -2.78 | |
13G/A | Mawer Investment Management Ltd. | 0.00 | -100.00 | |
13G/A | State Street Corp | 3.72 | -26.09 | |
13G/A | BlackRock Inc. | 13.10 | 3.38 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
286,086 | 1,999,344 | 14.31 | |
274,725 | 1,699,256 | 16.17 | |
243,871 | 1,551,049 | 15.72 | |
706,793 | 3,612,206 | 19.57 | |
(click for more detail) |
Similar Companies | |
---|---|
LLY – Eli Lilly and Company | MRK – Merck & Co., Inc. |
NUVB – Nuvation Bio Inc. | PBH – Prestige Consumer Healthcare Inc. |
PFE – Pfizer Inc. |
Financial data and stock pages provided by
Fintel.io